Brain Organid Culture Kit
abs90050-1kit
Rabbit anti-ATAD3C Polyclonal Antibody(Center)
abs103719-50uL
Rabbit anti-ErbB2 Recombinant Monoclonal Antibody(069-10)
abs171666-100uL
Rabbit anti-PRKCB Polyclonal Antibody
abs116899-50uL
Rabbit anti-COPB2 Polyclonal Antibody(C-term)
abs103713-50uL
Rabbit anti-CDKN2A Polyclonal Antibody
abs155444-100uL
Rabbit anti-PHC1 Polyclonal Antibody
abs116898-50uL
Rabbit anti-VSIG4 Polyclonal Antibody(C-term)
abs103696-50uL
Rabbit anti-IDO Polyclonal Antibody
abs155440-100uL
Rabbit anti-PRKCQ Polyclonal Antibody
abs116891-50uL
Organotal rat normal small intestinal organoid culture Kit
abs9762-1kit
Mouse anti-ERBB2 Monoclonal Antibody(1423CT594.76.52)
abs100477-50uL
Rabbit anti-Lamin B(Nuclear Loading Control) Polyclonal Antibody
abs155437-100uL
Rabbit anti-ING3 Polyclonal Antibody
abs116890-50uL
Organotal rat fetal normal colon organoid culture Kit
abs9761-1kit
Mouse anti-CHRM2 Monoclonal Antibody(1424CT461.78.60)
abs100476-50uL
Antifibrotic and antioxidant injectable hydrogel boosts endometrial repair and fertility via sGC/cGMP/SMAD7 signaling activation
Donghai Zhang, Liangsheng Li, Jingyi Zhou, Xiaofei Wang, Xiangyu Gao, Junfeng Chen, Tao Duan, Qiuhong Ma, Jigang Li , Yongsheng Yu, Qian Zhou
Chemical Engineering Journal. 2025 May 15 .
Influencing factors：13.3
Characterization of dsRNA binding proteins through solubility analysis identifies ZNF385A as a dsRNA homeostasis regulator
Na Jiang, Hekun Yang, Yi Lei, Weida Qin, Huifang Xiong, Kuan Chen, Kunrong Mei, Gongyu Li, Xin Mu, Ruibing Chen
Nat Commun. 2025 Apr 11 .
Influencing factors：14.7
Tumor-Derived CD109 Orchestrates Reprogramming of Tumor-Associated Macrophages to Dampen Immune Response
Tianming Cui, Linmao Sun, Xinyu Guo, Cheng Cheng, Ning Zhang, Shuo Zhou, Qi Chu, Changjian Xing, Shuhang Liang, Yufeng Liu, Changyong Ji, Xianying Li, Shengwei Tao, Xuetian Gu, Kun Ma, Chenghui Wu, Junhui Chu, Yumin Fu, Sitao Han, Yuchen Zhang, Jiareng Ye, Yao Liu, Jiabei Wang, Lianxin Liu
Journal of Hepatology. 2025 Apr 10 .
Influencing factors：26.8
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease
Taihua Yang, Jiahao Ge, Lei Huang, Xinye Zhu, Dexin Zhang, Siyuan Tang, Jie Zhao, Yinhe Ma, Mei Long, Xiaochen Bo, Jie Li, Yiqing Zhang, Qinggong Yuan, Amar Deep Sharma, Michael Ott, Hongquan Geng, Yicheng Zhao, Liang Zhang, Haifa Shen, Hangwen Li, Dali Li, Ping Wan, Qiang Xia
Sci Adv. 2025 Apr 9 .
Influencing factors：11.7
Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis
Tianliang Ma, Qimeng Liu, Zheyu Zhang, Jiangyu Nan, Guanzhi Liu, Yute Yang, Yihe Hu, Jie Xie
Bioact Mater. 2025 Apr 8 .
Influencing factors：18
Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer
Xianglei Fu, Yanbin Shi, Hang Wu, Yankun Zhang, Yingying Liu, Xiaoyu Wan, Xiangqin Chen, Jiamin Zhou, Shengnan Qiu, Xiaogang Zhao, Zhongxian Tian, Lian Li, Hengchang Zang, Guimei Lin
Nat Commun. 2025 Apr 8 .
Influencing factors：14.7